| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1From the Department of Ophthalmology and Visual Science, Osaka University Graduate School of Medicine 2Anatomy and Neuroscience, Osaka University Graduate School of Medicine, Osaka, Japan.
PURPOSE. To investigate whether triamcinolone acetonide (TA) affects the expression of vascular endothelial growth factor (VEGF) and connective tissue growth factor (CTGF) in retinal pigment epithelial (RPE) cells exposed to oxidative stress.
METHODS. TA (10 nM, 1 µM, or 100 µM) was added to ARPE19 cells exposed to oxidative stress induced by hypoxia-reoxygenation and paraquat. Cellular expression of VEGF, CTGF, and an inducer of both growth factors, transforming growth factor (TGF)-ß was investigated with real-time reverse transcription–polymerase chain reaction and Western blot analysis. Tube-forming assays were conducted with human umbilical vein endothelial cells (HUVECs) in conditioned medium from RPE cells exposed to oxidative stress, with or without TA treatment.
RESULTS. Oxidative stress induced mRNA expression of VEGF, CTGF, and TGF-ß by RPE cells. TA reduced upregulation of VEGF and TGF-ß in a concentration-dependent manner. In contrast, upregulation of CTGF by oxidative stress was accelerated by TA concentrations of 10 nM and 1 µM. Tube formation by HUVECs was strongly inhibited by exposure to conditioned medium from oxidative stress–stimulated ARPE19 cells treated with 1 µM TA compared with cells not treated with TA.
CONCLUSIONS. TA reduced VEGF expression and induced CTGF expression in ARPE19 cells exposed to oxidative stress, and conditioned medium from these cells inhibited tube formation by HUVECs. Because VEGF is a major cytokine involved in angiogenesis, and CTGF is a main cytokine related to fibrosis, these results suggest that changes in their expression may be important mechanisms underlying the decreased choroidal neovascularization and fibrosis after administration of TA.
This article has been cited by other articles:
|
|
 |
|
  O. Tatar, A. Adam, K. Shinoda, E. Kaiserling, V. Boeyden, C. Claes, C. Eckardt, T. Eckert, G. Pertile, G. B. Scharioth, et al. Early Effects of Intravitreal Triamcinolone Acetonide on Inflammation and Proliferation in Human Choroidal Neovascularization Arch Ophthalmol, March 1, 2009; 127(3): 275 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Yu, R. Fuchshofer, M. Birke, A. Kampik, H. Bloemendal, and U. Welge-Lussen Oxidative Stress and TGF-{beta}2 Increase Heat Shock Protein 27 Expression in Human Optic Nerve Head Astrocytes Invest. Ophthalmol. Vis. Sci., December 1, 2008; 49(12): 5403 - 5411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Tatar, K. Shinoda, E. Kaiserling, G. Pertile, C. Eckardt, A. Mohr, E. Yoeruek, P. Szurman, K. U. Bartz-Schmidt, and S. Grisanti Early Effects of Triamcinolone on Vascular Endothelial Growth Factor and Endostatin in Human Choroidal Neovascularization Arch Ophthalmol, February 1, 2008; 126(2): 193 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gauer, V. Segitz, and M. Goppelt-Struebe Aldosterone induces CTGF in mesangial cells by activation of the glucocorticoid receptor Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3154 - 3159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hollborn, C. Stathopoulos, A. Steffen, P. Wiedemann, L. Kohen, and A. Bringmann Positive Feedback Regulation between MMP-9 and VEGF in Human RPE Cells Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4360 - 4367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Ryan New pharmacologic approachesto treating diabetic retinopathy Am. J. Health Syst. Pharm., September 1, 2007; 64(17_Supplement_12): S15 - S21. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Obata, A Iriyama, Y Inoue, H Takahashi, Y Tamaki, and Y Yanagi Triamcinolone acetonide suppresses early proangiogenic response in retinal pigment epithelial cells after photodynamic therapy in vitro Br. J. Ophthalmol., January 1, 2007; 91(1): 100 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Ebrahem, A. Minamoto, G. Hoppe, B. Anand-Apte, and J. E. Sears Triamcinolone Acetonide Inhibits IL-6- and VEGF-Induced Angiogenesis Downstream of the IL-6 and VEGF Receptors Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4935 - 4941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Hartnett, D. J. Martiniuk, Y. Saito, P. Geisen, L. J. Peterson, and J. R. McColm Triamcinolone Reduces Neovascularization, Capillary Density and IGF-1 Receptor Phosphorylation in a Model of Oxygen-Induced Retinopathy Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4975 - 4982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Saelzler, C. C. Spackman, Y. Liu, L. C. Martinez, J. P. Harris, and M. K. Abe ERK8 Down-regulates Transactivation of the Glucocorticoid Receptor through Hic-5 J. Biol. Chem., June 16, 2006; 281(24): 16821 - 16832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zarbin Should corticosteroids be considered as part of the standard care with photodynamic therapy? Arch Ophthalmol, April 1, 2006; 124(4): 563 - 571. [Full Text] [PDF]
|
|
|
|
|
|
W-M Chan, T Y Y Lai, A L Wong, J-P Tong, D T L Liu, and D S C Lam Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study. Br. J. Ophthalmol., March 1, 2006; 90(3): 337 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Uckermann, F. Kutzera, A. Wolf, T. Pannicke, A. Reichenbach, P. Wiedemann, S. Wolf, and A. Bringmann The Glucocorticoid Triamcinolone Acetonide Inhibits Osmotic Swelling of Retinal Glial Cells via Stimulation of Endogenous Adenosine Signaling J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1036 - 1045. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
